Purchases and Sales Made in Q1 2024 in Werewolf Therapeutics, Inc. (HOWL)
This table provides information about the institutional ownership of Werewolf Therapeutics, Inc. (HOWL) during Q1 2024. The information is specifically focused on institutions that hold shares of Werewolf Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 13, 2024
Q1 2024
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-23.3K- 21.68% |
$91.4K - $184K
|
84.2K
$121K
|
|
|
Oct 17, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-28.4K- 58.01% |
$111K - $225K
|
20.6K
$29.6K
|
|
|
May 15, 2024
Q1 2024
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
SELL
|
- |
-33.7K- 1.11% |
$132K - $266K
|
3M
$4.32M
|
|
|
May 15, 2024
Q1 2024
|
Alyeska Investment Group, L.P.
Chicago, IL |
SELL
|
- |
-200K- 45.9% |
$784K - $1.58M
|
236K
$339K
|
|
|
May 15, 2024
Q1 2024
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-215K- 10.26% |
$843K - $1.7M
|
1.88M
$2.71M
|
|
|
May 10, 2024
Q1 2024
|
Rubric Capital Management LP
New York, NY |
SELL
|
- |
-314K- 16.24% |
$1.23M - $2.49M
|
1.62M
$2.33M
|
|
|
May 14, 2024
Q1 2024
|
Pfm Health Sciences, LP
San Francisco, CA |
SELL
|
- |
-461K- 13.31% |
$1.81M - $3.65M
|
3.01M
$4.33M
|